International expert consensus on gene therapy for hereditary hearing loss: Based on clinical trials
Xintai Fan(Eye & ENT Hospital of Fudan University), Xia Gao(Heilongjiang University of Science and Technology), Wei Yuan(Shanghai Public Health Clinical Center), Haidi Yang(Sun Yat-sen University), Ziwen Gao(Fudan University), Chen‐Chi Wu(National Taiwan University), Nicola Strenzke(Universitätsmedizin Göttingen), Yong Tao(Shanghai Ninth People's Hospital), Yong Feng(University of Hong Kong), Yongfu Yu(Fudan University), Di Zhang(Wuhan University of Technology), Xiaoting Cheng(Fudan University), Wade W. Chien(Johns Hopkins University), Nikul Amin(Great Ormond Street Hospital), Manohar Bance(Addenbrooke's Hospital), Barbara Vona(Brigham and Women's Hospital), Luoying Jiang(Fudan University), Daqi Wang(Liaocheng University), Tobias Moser(Universitätsmedizin Göttingen), Jun Lv(Shanghai Jiao Tong University), Yu Sun(China-Japan Friendship Hospital), Jiake Zhong(Fudan University), Liheng Chen(Fudan University), Xin Jin(Chinese Journal of Integrated Traditional and Western Medicine), Guodong Feng(Chinese Academy of Medical Sciences & Peking Union Medical College), James Arwyn–Jones(Great Ormond Street Hospital), Yen‐Fu Cheng(Massachusetts Eye and Ear Infirmary), Wuqing Wang(Fudan University), Lukas D. Landegger(Medical University of Vienna), Dirk Beutner(Universitätsmedizin Göttingen), Dazhi Shi(University of South China), John H. Greinwald(Cincinnati Children's Hospital Medical Center), Jian‐Ming Yang(Ministry of Education), Yongxin Li(Beijing Tongren Hospital), Yuxin Chen(Fudan University), Qin Wang(Georgetown University), Lei Xu(Shandong University), Luo Guo(Zunyi Medical University), Sang‐Yeon Lee(Seoul National University), Yanbo Yin(Fudan University), Dan Jiang(Guy's and St Thomas' NHS Foundation Trust), Shuang Han(Eye & ENT Hospital of Fudan University), Yu Zhao(BGI Group (China)), Chong Cui(Fudan University), Xiaoyun Chen(Fujian Medical University), Fan-Gang Zeng(University of California, Irvine), Robert Nash(Great Ormond Street Hospital), Deepak Chandrasekeharan(Great Ormond Street Hospital), Jieyu Qi(Medical Protective)
Cited by 4
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2019|649
Photoplethysmography Revisited: From Contact to Noncontact, From Point to Imaging
|IEEE Transactions on Biomedical Engineering|2015|551
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
|Nature|2017|547
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
|European Urology|2019|464